Found: 33
Select item for more details and to access through your institution.
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Novel therapeutic avenues in myeloma: changing the treatment paradigm.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
New treatments for multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition.
- Published in:
- Oncogene, 2010, v. 29, n. 16, p. 2325, doi. 10.1038/onc.2009.510
- By:
- Publication type:
- Article
A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
- Published in:
- Oncogene, 2008, v. 27, n. 6, p. 721, doi. 10.1038/sj.onc.1210679
- By:
- Publication type:
- Article
A novel Bcl-2/Bcl-X<sub>L</sub>/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma.
- Published in:
- Oncogene, 2007, v. 26, n. 16, p. 2374, doi. 10.1038/sj.onc.1210028
- By:
- Publication type:
- Article
Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Detection of chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
- Published in:
- Immunology, 1990, v. 69, n. 3, p. 396
- By:
- Publication type:
- Article
Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 9, p. 1918, doi. 10.1038/leu.2015.83
- By:
- Publication type:
- Article
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.
- Published in:
- Leukemia (08876924), 2015, v. 29, n. 2, p. 510, doi. 10.1038/leu.2014.300
- By:
- Publication type:
- Article
Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 680, doi. 10.1038/leu.2013.231
- By:
- Publication type:
- Article
Induction of differential apoptotic pathways in multiple myeloma cells by class-selective histone deacetylase inhibitors.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 457, doi. 10.1038/leu.2013.301
- By:
- Publication type:
- Article
Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 12, p. 2366, doi. 10.1038/leu.2013.194
- By:
- Publication type:
- Article
β-catenin is dynamically stored and cleared in multiple myeloma by the proteasome-aggresome-autophagosome-lysosome pathway.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1116, doi. 10.1038/leu.2011.303
- By:
- Publication type:
- Article
A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
- Published in:
- 2011
- By:
- Publication type:
- journal article
HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The use of novel agents in the treatment of relapsed and refractory multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Ascorbic acid inhibits antitumor activity of bortezomib in vivo.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 9, p. 1679, doi. 10.1038/leu.2009.83
- By:
- Publication type:
- Article
Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 5, p. 961, doi. 10.1038/leu.2008.378
- By:
- Publication type:
- Article
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma.
- Published in:
- Leukemia (08876924), 2008, v. 22, n. 10, p. 1925, doi. 10.1038/leu.2008.174
- By:
- Publication type:
- Article
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 12, p. 2519, doi. 10.1038/sj.leu.2404912
- By:
- Publication type:
- Article
Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of β-catenin/TCF pathway.
- Published in:
- Leukemia (08876924), 2007, v. 21, n. 3, p. 535, doi. 10.1038/sj.leu.2404561
- By:
- Publication type:
- Article
Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 7, p. 1253, doi. 10.1038/sj.leu.2403776
- By:
- Publication type:
- Article
Immunomodulatory analogs of thalidomide inhibit growth of Hs Sultan cells and angiogenesis in vivo.
- Published in:
- Leukemia (08876924), 2003, v. 17, n. 1, p. 41, doi. 10.1038/sj.leu.2402745
- By:
- Publication type:
- Article
Video-assisted thoracoscopic esophagectomy for esophageal cancer.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2006, v. 135, n. 1, p. 52, doi. 10.1111/j.1365-2141.2006.06261.x
- By:
- Publication type:
- Article
2-Methoxyestardiol and bortezomib/proteasome-inhibitor overcome dexamethasone-resistance in multiple myeloma cells by modulating Heat Shock Protein-27.
- Published in:
- Apoptosis, 2004, v. 9, n. 2, p. 149, doi. 10.1023/B:APPT.0000018797.66067.6c
- By:
- Publication type:
- Article
A novel proteasome inhibitor NPI-0052 as an anticancer therapy.
- Published in:
- British Journal of Cancer, 2006, v. 95, n. 8, p. 961, doi. 10.1038/sj.bjc.6603406
- By:
- Publication type:
- Article
Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation.
- Published in:
- British Journal of Cancer, 1999, v. 79, n. 9/10, p. 1549, doi. 10.1038/sj.bjc.6690247
- By:
- Publication type:
- Article